How much is the Immunotherapy Drugs Market market?

The immunotherapy drugs market market size is estimated to grow at $$ 111.35 bn in 2023. Read More

What is the growth rate of the Immunotherapy Drugs Market market?

The growth rate of the immunotherapy drugs market year-over-year is 11.31%. Read More

Which region held the largest market share in the Immunotherapy Drugs Market market?

North America is the region to held the largest market share with 43% growth. Read More

Who are the key players in the Immunotherapy Drugs Market market?

AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, BioNTech SE, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celldex Therapeutics Inc., F. Hoffmann La Roche .... Read More

Which Segment has the largest market share in the Immunotherapy Drugs Market market?

End-user is the segment that has the largest market share in the market. Read More

Immunotherapy Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 163
SKU: IRTNTR76823

Enjoy complimentary customisation on priority with our Enterprise License!

Immunotherapy Drugs Market Size 2024-2028

The Global Immunotherapy Drugs Market size is estimated to grow by USD 111.35 billion, at a CAGR of 11.31% between 2023 and 2028. The increasing prevalence of cancer, driven by factors such as aging populations and lifestyle changes, is leading to a greater demand for cancer treatments and therapies. Growing investments in pharmaceutical technology, such as advancements in drug delivery systems and personalized medicine, are driving innovation in the industry and creating new opportunities for growth. Increasing awareness in patients, fueled by initiatives from healthcare organizations and advocacy groups, is leading to earlier detection and treatment of diseases, further driving market growth.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by End-user, Type and Geography Analysis

By End-user

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global immunotherapy drugs market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global immunotherapy drugs market 2018 - 2022 ($ billion)

4.2 End-user Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)

4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user

6.3 Hospitals - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

6.4 Clinics - Market size and forecast 2023-2028
- Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)

6.5 Others - Market size and forecast 2023-2028
- Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by End-user
- Exhibit 46: Market opportunity by End-user ($ billion)
- Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 48: Chart on Type - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type
- Exhibit 50: Chart on Comparison by Type
- Exhibit 51: Data Table on Comparison by Type

7.3 Monoclonal antibodies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)

7.4 Vaccines - Market size and forecast 2023-2028
- Exhibit 56: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)

7.5 Immune checkpoint inhibitors - Market size and forecast 2023-2028
- Exhibit 60: Chart on Immune checkpoint inhibitors - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Immune checkpoint inhibitors - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Immune checkpoint inhibitors - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Immune checkpoint inhibitors - Year-over-year growth 2023-2028 (%)

7.6 Others - Market size and forecast 2023-2028
- Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by Type
- Exhibit 68: Market opportunity by Type ($ billion)
- Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 Japan - Market size and forecast 2023-2028
- Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption

11.4 Industry risks
- Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 117: Vendors covered

12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification

12.3 AbbVie Inc.
- Exhibit 119: AbbVie Inc. - Overview
- Exhibit 120: AbbVie Inc. - Product / Service
- Exhibit 121: AbbVie Inc. - Key news
- Exhibit 122: AbbVie Inc. - Key offerings

12.4 Amgen Inc.
- Exhibit 123: Amgen Inc. - Overview
- Exhibit 124: Amgen Inc. - Product / Service
- Exhibit 125: Amgen Inc. - Key offerings

12.5 AstraZeneca Plc
- Exhibit 126: AstraZeneca Plc - Overview
- Exhibit 127: AstraZeneca Plc - Product / Service
- Exhibit 128: AstraZeneca Plc - Key news
- Exhibit 129: AstraZeneca Plc - Key offerings

12.6 Bayer AG
- Exhibit 130: Bayer AG - Overview
- Exhibit 131: Bayer AG - Business segments
- Exhibit 132: Bayer AG - Key news
- Exhibit 133: Bayer AG - Key offerings
- Exhibit 134: Bayer AG - Segment focus

12.7 BioNTech SE
- Exhibit 135: BioNTech SE - Overview
- Exhibit 136: BioNTech SE - Product / Service
- Exhibit 137: BioNTech SE - Key offerings

12.8 Boehringer Ingelheim International GmbH
- Exhibit 138: Boehringer Ingelheim International GmbH - Overview
- Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 140: Boehringer Ingelheim International GmbH - Key news
- Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus

12.9 Bristol Myers Squibb Co.
- Exhibit 143: Bristol Myers Squibb Co. - Overview
- Exhibit 144: Bristol Myers Squibb Co. - Product / Service
- Exhibit 145: Bristol Myers Squibb Co. - Key news
- Exhibit 146: Bristol Myers Squibb Co. - Key offerings

12.10 F. Hoffmann La Roche Ltd.
- Exhibit 147: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 149: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus

12.11 Gilead Sciences Inc.
- Exhibit 152: Gilead Sciences Inc. - Overview
- Exhibit 153: Gilead Sciences Inc. - Product / Service
- Exhibit 154: Gilead Sciences Inc. - Key news
- Exhibit 155: Gilead Sciences Inc. - Key offerings

12.12 GlaxoSmithKline Plc
- Exhibit 156: GlaxoSmithKline Plc - Overview
- Exhibit 157: GlaxoSmithKline Plc - Business segments
- Exhibit 158: GlaxoSmithKline Plc - Key news
- Exhibit 159: GlaxoSmithKline Plc - Key offerings
- Exhibit 160: GlaxoSmithKline Plc - Segment focus

12.13 Immatics NV
- Exhibit 161: Immatics NV - Overview
- Exhibit 162: Immatics NV - Product / Service
- Exhibit 163: Immatics NV - Key offerings

12.14 Johnson and Johnson
- Exhibit 164: Johnson and Johnson - Overview
- Exhibit 165: Johnson and Johnson - Business segments
- Exhibit 166: Johnson and Johnson - Key news
- Exhibit 167: Johnson and Johnson - Key offerings
- Exhibit 168: Johnson and Johnson - Segment focus

12.15 Novartis AG
- Exhibit 169: Novartis AG - Overview
- Exhibit 170: Novartis AG - Business segments
- Exhibit 171: Novartis AG - Key offerings
- Exhibit 172: Novartis AG - Segment focus

12.16 Pfizer Inc.
- Exhibit 173: Pfizer Inc. - Overview
- Exhibit 174: Pfizer Inc. - Product / Service
- Exhibit 175: Pfizer Inc. - Key news
- Exhibit 176: Pfizer Inc. - Key offerings

12.17 Sanofi SA
- Exhibit 177: Sanofi SA - Overview
- Exhibit 178: Sanofi SA - Business segments
- Exhibit 179: Sanofi SA - Key news
- Exhibit 180: Sanofi SA - Key offerings
- Exhibit 181: Sanofi SA - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 182: Inclusions checklist
- Exhibit 183: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 184: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 185: Research methodology
- Exhibit 186: Validation techniques employed for market sizing
- Exhibit 187: Information sources